https://youtu.be/wKPiFWdsaFY Key highlights from Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Management Update: GLAND said it is experiencing increased attrition and
Gland Pharma Ltd
-(GLAND)
XNSE:GLAND, XBOM:GLAND
Gland Pharma Ltd. for Q1FY23 reports a 35% fall in Profits
Revenue has fell by 26% YoY to ₹8,569 millions. Core Market Revenue has decreased by 6% and Rest of the world revenue
Gland Pharma Limited (GLAND) Q1 FY23 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q1 FY23 Earnings Concall dated Jul. 20, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President, Corporate Finance and Investor
Gland Pharma Ltd. (GLAND) Q4 FY22 Earnings Concall Transcript
Gland Pharma Ltd. (NSE: GLAND) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Sumanta Bajpayee -- Vice President-Finance & Investor Relations Srinivas
Gland Pharma Ltd (GLAND) Q3 FY22 Earnings Concall Transcript
Gland Pharma Limited (NSE:GLAND) Q3 FY22 Earnings Concall dated Jan. 21, 2022 Corporate participants: Sumanta Bajpayee -- Vice President- Investor Relations Srinivas